Frequency and characteristics of additionally detected ipsilateral breast lesions following recall at screening mammography

Joost R. C. Lameijer*, Angela M. P. Coolen, Joost Nederend, Adri C. Voogd, Vivianne C. G. Tjan-Heijnen, Lucien E. M. Duijm

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose: To determine the frequency and outcome of additionally detected ipsilateral breast abnormalities following recall at screening mammography.

Methods and materials: We included a consecutive series of 130,338 screening mammograms obtained between January 1, 2014 and January 1, 2016. During 2-year follow-up, clinical data were collected of all recalls. Women with a bilateral recall (115) and women recalled for multiple lesions in one breast (165) were excluded from the analyses. Screening outcome parameters were determined for recalled women with or without evaluation of additional ipsilateral breast abnormalities following recall.

Results: A total of 3995 women were recalled (recall rate, 3.1%). In 258 (6.4%) of these women, another lesion was detected in the ipsilateral breast than the one for which she had been recalled. Biopsy was more frequently performed of additionally detected ipsilateral lesions than of recalled lesions (55.8% (144/258)) versus 39.7% (1375/3457), (p

Conclusion: A substantial proportion of women are analyzed for additional ipsilateral breast lesions following recall. These lesions are more frequently biopsied than recalled lesions, but have a comparable probability of being malignant. The majority of additionally detected cancerous lesions are part of multifocal or multicentric malignancies. (C) 2018 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)94-101
Number of pages8
JournalBreast
Volume42
DOIs
Publication statusPublished - Dec 2018

Keywords

  • Epidemiology
  • Breast cancer
  • Screening
  • Malignancy
  • Ipsilateral lesion
  • ENHANCED SPECTRAL MAMMOGRAPHY
  • DIGITAL MAMMOGRAPHY
  • MULTICENTRIC CANCER
  • 2D MAMMOGRAPHY
  • TOMOSYNTHESIS
  • METAANALYSIS
  • ACCURACY
  • PROGRAM
  • IMPACT
  • TRIAL

Cite this